Carsten Hopf obtained his PhD in Biochemistry from Tübingen University/Max-Planck-Institute for Developmental Biology. As an EMBO fellow in Neuroscience, he worked at the Johns Hopkins University School of Medicine for three years before joining Cellzome AG, a proteomics-focused drug discovery platform company in Heidelberg, in 2001.

For 13 years, he served in multiple roles in platform technology, assay development, drug discovery, and business development, eventually becoming part of Cellzome’s leadership team until 2014.

Since 2005, he has been a Professor of Bioanalytics, Proteomics, and Drug Discovery at Mannheim University of Applied Sciences. He currently heads the Center of Mass Spectrometry and Optical Spectroscopy (CeMOS) and the M²Aind partnership for innovation in the health industry in Mannheim. Additionally, he serves on boards of biomedical clusters.

He is also an Associated Professor in the Medical and Biosciences Faculties of Heidelberg University and Co-chair for “Imaging” of the German Society for Mass Spectrometry (DGMS).